Home > Divisions > CSIRO Molecular & Health Technologies

Explore CSIRO

About CSIRO

The Commonwealth Scientific and Industrial Research Organisation is Australia's national science agency and one of the largest and most diverse research agencies in the world.

CSIRO's core areas of impact

Contact Enquiries: Phone - 1300 363 400 | Email - Enquiries@csiro.au | Contact Us
A decorative image of a molecule. Text says 'CSIRO Molecular and Health Technologies'.
Man's blue eye

Our researchers are developing and evaluating new platform materials and devices for applications in tissue repair, replacement and regeneration.

Two scientists looking at RAFT details on a board.

This technology enables new generation and innovative materials to be produced for use in biomedical, industrial and energy applications. RAFT is a sophisticated form of controlled free radical polymerisation.

Image of a scientist in holding a pipette.
CSIRO's Australian Biotech Growth Partnerships supports the growth of the biotechnology industry and is currently working with over 50 companies.
We deliver benefits to the economy, society and the environment. See some of our achievements and solutions.
Worldwide, CSIRO is involved in over 850 current or recently completed research activities. See some examples here.
We provide a range of partnering and technology transfer arrangements. See some examples here.
Sixty per cent of CSIRO staff hold university degrees, including more than 1850 doctors and 420 masters. Meet our staff working in Molecular & Health Technologies.
See the products, publications and fact sheets from the Molecular & Health Technologies Division.

CSIRO offers more than 50 specialised technical and analytical services. CSIRO Molecular & Health Technologies offers the following capabilities, facilities and services.

CSIRO has 57 sites throughout Australia and overseas. Read about our Molecular & Health Technologies' sites.

See the latest news from CSIRO Molecular and Health Technologies.

See the events that CSIRO Molecular Health and Technologies are involved in.

Reversible Addition-Fragmentation chain Transfer (RAFT) technology is a sophisticated form of controlled free radical polymerisation which enables the synthesis of tailored polymers.

CSIRO's Biomedical Materials research develops and evaluates new materials and devices for tissue repair, replacement and regeneration.

 

Related Areas

Themes

Primary contact

Ms Sam Carroll
Marketing and Communication Manager
Materials Science and Engineering
Phone: 61 3 9662 7344 
Alt Phone: 61 4 0811 7846 
Fax: 61 3 9545 2447 

CSIRO Materials Science and Engineering - Clayton
Office: Bayview Avenue
Clayton VIC 3168
Australia

Post: Private Bag 10
Clayton VIC 3169
Australia